In The News
NAB super fund trustee says failed class action rejected $25M offer
All judges immune from civil suits for judicial actions, High Court says
BHP class action can expand group definition, but not retroactively
‘Red flags, red suitcases’: Star GC warned of unacceptable risk, court told
Exactech class action stayed after judge recognises US bankruptcy
Allianz not on hook for Knox Grammar abuse claims: Full Court
Judge complains of ‘spiralling costs’ of expert evidence in class actions
ACT government can’t get quick win in social housing class action
Homes Victoria docs shielded from public housing class action, court rules
Enviro group takes Tamboran to court over Beetaloo Basin fracking
Please login to bookmark Close

The Australian Competition and Consumer Commission will not oppose the acquisition of global pharmaceutical giant Bayer’s animal health business by competitor Elanco, after the company agreed to divest certain brands to allay competition concerns.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au